Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year

Life Science

Kolon Life Science to Export $207 Million of Gene Therapy Treatment to China’s Hainan Province

Life Science

Shanghai Fosun Pharma Considering $500 Million IPO of Gland Pharma

Life Science

Quantapore Inc. Closes Series 3 Financing Round to Fund Beta Launch of DNA Sequencer

Life Science

Alpine Immune Sciences Completes Sale of S-Nitrosoglutathione Reductase (GSNOR) Assets to Laurel Venture Capital

Life Science

Shanghai Pharmas Form Union to Fix Short Supply of Drugs for Rare Diseases

Life Science

Canadian marijuana company Tilray has first US pot IPO

Cannabis, Life Science

Takeda Eyes China Drug Market as its Next Big Opportunity Following Shire Deal

Life Science

Shuwen Biotech’s Clinical Lab Successfully Passes Biyearly College of American Pathologists Audit

Life Science

Tianjin Tasly in $24 Million Deal for EA Pharma Kidney Disease Drug

Life Science

Ascletis’ Hong Kong IPO to Raise $457 Million at $2 Billion Valuation

Life Science

Life Science & Technology Weekly 152 – China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing

Cannabis, Life Science

Aphria announces proposed acquisitions in Latin America, Jamaica worth around $200 million

Cannabis, Life Science

Fosun Pharma to Invest $17.6 Million in EOS Imaging of France

Life Science

Sinovant Formed with 11 China Drug Candidates and CITICPE Support

Life Science